Amalgamated Bank Infinity Pharmaceuticals, Inc. Transaction History

Amalgamated Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $6,798 - $16,650	-13,875 Closed	0 $0
Q1 2022 Jun 30, 2022	SELL	$0.85 - $2.4 $992 - $2,803	-1,168 Reduced 7.76%	13,875 $16,000
Q4 2021 Feb 15, 2022	SELL	$1.86 - $3.36 $980 - $1,770	-527 Reduced 3.38%	15,043 $34,000
Q3 2021 Oct 29, 2021	SELL	$1.52 - $3.82 $813 - $2,043	-535 Reduced 3.32%	15,570 $53,000
Q2 2021 Aug 16, 2021	BUY	$2.66 - $3.47 $42,839 - $55,884	16,105 New	16,105 $48,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.